Javier Lopez Alonso

Javier  Lopez Alonso on Linkedin

Javier  Lopez Alonso is Treasurer/Co-Founder of Asociacion De Investigacion En Inteligencia Artificial Para La Leucemia Peter Moss and a PhD student from Spain with a BA in pharmacy from the University of Barcelona.

Javier  Lopez Alonso
Javier  Lopez Alonso on Linkedin

Javier Lopez Alonso

Treasurer / R&D
PhD Student, BA in Pharmacy
Institut Pasteur de Lille

Javier is a PhD student from Spain with a BA in pharmacy from the University of Barcelona and Treasurer/Co-Founder of Asociacion De Investigacion En Inteligencia Artificial Para La Leucemia Peter Moss.

At the moment Javier is working on his PhD, which focuses on the development of sample preparation, instrumentation, and operational settings to measure nano-mechanics parameters of eukaryotic cells/tissues in an automated way. This method will then be applied to various cell types and tissue collected from patients suffering from lung or kidney cancer.

Javier is a person who loves learning and tinkering with technology. On his day-to-day, he mostly works on Atomic Force Microscopy (AFM) and the development of software at the lab is done using the Python programming language.

After specializing in Industrial Pharmacy and Pharmaceutical research at university, Javier gained real-world knowledge at the Service of Development of Medicines (Pharmacy Faculty, University of Barcelona) assisting in drug development. Expanding on that experience, Javi did a Postgraduate course in Quality Assurance applied in drug R&D; and worked for a year at Bigfinite, a bioinformatics startup, helping to develop quality control systems and ensuring data integrity. At Bigfinite, Javi also learned industry-standard automated software testing and acquired Python coding knowledge with voluntary courses and veteran mentors.

Leukemia AI Research

De Asociacion De Investigation En Intelligencia Artificial Para La Leucemia Peter Moss is a non profit research association dedicated to researching into the Artificial Intelligence and other modern technologies, and how they can be used in the fight against Leukemia and other blood cancers.

| |